ArticleCirculation research2018
Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone".
Miranda E Good, Yu-Hsin Chiu, Ivan K H Poon, Iris Z Jaffe, Douglas A Bayliss, Brant E Isakson, Kodi S Ravichandran
Open access · bronzeAbstract readLetterComment
In one paragraphArticle in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors at 3 institutions in 2 countries.
Miranda E GoodDepartment of Molecular Physiology and Biophysics, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville.
Yu-Hsin ChiuDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville.
Ivan K H PoonDepartment of Biochemistry and Genetics, La Trobe University, Melbourne, Australia.
Iris Z JaffeMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Douglas A BaylissDepartment of Pharmacology, University of Virginia School of Medicine, Charlottesville.
Brant E IsaksonDepartment of Molecular Physiology and Biophysics, Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville.
Kodi S RavichandranDepartment of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville.
University of Virginia · USLa Trobe University · AUTufts Medical Center · US
Funding
Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2014 to 2023
$24.0MSmooth Muscle Mineralocorticoid Receptors in Vascular Aging and HypertensionR01HL119290 · NHLBI · TUFTS MEDICAL CENTER · PI Iris Z Jaffe · 2014 to 2026
$7.0MNHLBI NIH HHS P01 HL120840NHLBI NIH HHS R01 HL119290
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antihypertensive AgentsSpironolactoneMineralocorticoid Receptor AntagonistsAntihypertensive AgentsMineralocorticoid Receptor AntagonistsSpironolactone
Identifiers
PMID29798905
PMCPMC6051405
OpenAlexW2804561289
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390